Dataset Information

In vitro exposure system for study of aerosolized influenza virus.

ABSTRACT: Infection of adherent cell monolayers using a liquid inoculum represents an established method to reliably and quantitatively study virus infection, but poorly recapitulates the exposure and infection of cells in the respiratory tract that occurs during infection with aerosolized pathogens. To better simulate natural infection in vitro, we adapted a system that generates viral aerosols similar to those exhaled by infected humans to the inoculation of epithelial cell monolayers. Procedures for cellular infection and calculation of exposure dose were developed and tested using viruses characterized by distinct transmission and pathogenicity phenotypes: an HPAI H5N1, an LPAI H7N9, and a seasonal H3N2 virus. While all three aerosolized viruses were highly infectious in a human bronchial epithelial cell line (Calu-3) cultured submerged in media, differences between the viruses were observed in primary human alveolar epithelial cells and in Calu-3 cells cultured at air-liquid interface. This system provides a novel enhancement to traditional in vitro experiments, particularly those focused on the early stages of infection.

SUBMITTER: Creager HM

PROVIDER: S-EPMC5221479 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

In vitro exposure system for study of aerosolized influenza virus.

Creager Hannah M HM Zeng Hui H Pulit-Penaloza Joanna A JA Maines Taronna R TR Tumpey Terrence M TM Belser Jessica A JA

Virology 20161020

Infection of adherent cell monolayers using a liquid inoculum represents an established method to reliably and quantitatively study virus infection, but poorly recapitulates the exposure and infection of cells in the respiratory tract that occurs during infection with aerosolized pathogens. To better simulate natural infection in vitro, we adapted a system that generates viral aerosols similar to those exhaled by infected humans to the inoculation of epithelial cell monolayers. Procedures for ce ...[more]

PMID: 27771560

Similar Datasets

Project description:Although it causes only mild respiratory disease, influenza D virus (IDV) is implicated in bovine respiratory disease complex (BRDC), which is a major cause of economic concern for cattle producers globally. The virus replicates in the upper and lower respiratory tract with virus titre highest in nasal turbinates. We therefore hypothesised that the bovine turbinate (BT) cell line could provide a useful in vitro model to study viral–host interactions. Host gene expression was determined using RNA-Seq. Significantly differentially expressed genes with respect to mock-infected cells were identified using DESeq2 and KEGG pathway analysis used to determine enriched pathways. Psuedotyped viruses were used to show the involvement of intrinsic innate immune responses including IFN-inducible transmembrane (IFITM) proteins in restricting the entry of IAV, ICV and IDV. Localization of bovine IFITM3 was determined using immunofluorescence assay. Pull-down and immunoprecipitation assays were used to detect binding of IDV NS1 to p85β subunit of the PI3K pathway. RNA-Seq demonstrated the involvement of genes related to type I or type III interferon responses in IDV infection of BT cells. Intrinsic innate immune responses including IFN-inducible transmembrane (IFITM) proteins restricted the entry of IAV, ICV and IDV pseudotyped viruses. Determination of the subcellular localization of bovine IFITM3 showed that it has an intracellular cytoplasmic distribution. KEGG pathway analysis of the transcriptomic data showed activation of the PI3K/Akt pathway. This led to the hypothesis that IDV activates the pathway in a similar way to influenza A virus (IAV), by non-structural NS1 protein binding the PI3K p85β subunit. However, pull-down and immunoprecipitation assays did not detect binding of IDV NS1 to p85β; this may be due to amino acid differences in the tyrosine-phosphorylated YXXXM motif that is important in the binding of the IAV NS1 to the p85β subunit. This suggests a different mechanism in preventing apoptosis after IDV infection. In conclusion, this study has shown the efficient replication of IDV in bovine turbinate cells. The study has also shown the involvement of type I interferon responses in immune response to IDV infection of cells of the upper respiratory tract of the cow. There is the involvement of different signalling pathways including the FoXO and PI3K/Akt pathway in IDV infection. Bovine IFITM3 is localised intracellularly and is involved in the restriction of IDV entry.

Project description:Influenza is an infectious respiratory illness caused by influenza viruses. Despite yearly updates, the efficacy of influenza vaccines is significantly curtailed by the virus antigenic drift and antigenic shift. These constant changes to the influenza virus make-up also challenge the development of a universal flu vaccine, which requires conserved antigenic regions shared by influenza viruses of different subtypes. We propose that it is possible to bypass these challenges by the development of an influenza vaccine based on conserved proteins delivered in an adjuvanted nanoparticle system. In this study, we generated influenza nanoparticle constructs using trimethyl chitosan nanoparticles (TMC nPs) as the carrier of recombinant influenza hemagglutinin subunit 2 (HA2) and nucleoprotein (NP). The purified HA2 and NP recombinant proteins were encapsulated into TMC nPs to form HA2-TMC nPs and NP-TMC nPs, respectively. Primary human intranasal epithelium cells (HNEpCs) were used as an in vitro model to measure immunity responses. HA2-TMC nPs, NP-TMC nPs, and HA2-NP-TMC nPs (influenza nanoparticle constructs) showed no toxicity in HNEpCs. The loading efficiency of HA2 and NP into the TMC nPs was 97.9% and 98.5%, respectively. HA2-TMC nPs and NP-TMC nPs more efficiently delivered HA2 and NP proteins to HNEpCs than soluble HA2 and NP proteins alone. The induction of various cytokines and chemokines was more evident in influenza nanoparticle construct-treated HNEpCs than in soluble protein-treated HNEpCs. In addition, soluble factors secreted by influenza nanoparticle construct-treated HNEpCs significantly induced MoDCs maturation markers (CD80, CD83, CD86 and HLA-DR), as compared to soluble factors secreted by protein-treated HNEpCs. HNEpCs treated with the influenza nanoparticle constructs significantly reduced influenza virus replication in an in vitro challenge assay. The results indicate that TMC nPs can be used as influenza vaccine adjuvants and carriers capable of delivering HA2 and NP proteins to HNEpCs.

Dataset Information

In vitro exposure system for study of aerosolized influenza virus.

Publications

In vitro exposure system for study of aerosolized influenza virus.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets